Introducing a world ofElevated Factor IX levels
that last for years
Educating healthcare professionals about a new level
of freedom for patients from the impact of hemophila B
With the FDA approval of HEMGENIX, patients are now free to enter a
new
world of possibilities that once represented previously unattainable
goals.
The HEMGENIX interactive visual aid walks healthcare professionals
through
the unmet treatment needs of people with hemophilia B and how the
HEMGENIX
efficacy and safety may meet those needs, while also providing
education on a
completely novel form of treatment, gene therapy.
